Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Apr;117(4 Suppl):S525-53.
doi: 10.1016/j.jaci.2006.01.015.

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

Jordan S Orange  1 , Elham M Hossny, Catherine R Weiler, Mark Ballow, Melvin Berger, Francisco A Bonilla, Rebecca Buckley, Javier Chinen, Yehia El-Gamal, Bruce D Mazer, Robert P Nelson Jr, Dhavalkumar D Patel, Elizabeth Secord, Ricardo U Sorensen, Richard L Wasserman, Charlotte Cunningham-Rundles; Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
Affiliations
Review

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

Jordan S Orange et al. J Allergy Clin Immunol. 2006 Apr.

Erratum in

  • J Allergy Clin Immunol. 2006 Jun;117(6):1483. Dosage error in article text

Abstract

Human immunoglobulin prepared for intravenous administration (IGIV) has a number of important uses in the treatment of disease. Some of these are in diseases for which acceptable treatment alternatives do not exist. In this review we have evaluated the evidence underlying a wide variety of IGIV uses and make specific recommendations on the basis of these data. Given the potential risks and inherent scarcity of IGIV, careful consideration of the indications for and administration of IGIV is warranted.

PubMed Disclaimer

MeSH terms

Substances

LinkOut - more resources